National Health Amendment (Passive Immunological Products) Bill 2026

# National Health Amendment (Passive Immunological Products) Bill 2026 ## What it does This bill updates Australia's health laws to officially recognise passive immunity products—like antibody treatments and immunoglobulins—alongside traditional vaccines. Previously, the law only covered vaccines that work through "active immunity" (where your body makes its own antibodies). Now it includes passive immunity products (where you receive ready-made antibodies directly). ## Why it matters As medical science develops new types of immunological treatments, the law needs to catch up so these products can be properly regulated and funded through Australia's health system. This change removes a legal gap that could have prevented Australians accessing newer protective treatments. ## Key details - **What changes**: The definition of "vaccine" in the National Health Act 1953 is broadened to explicitly include both active and passive immunity preparations - **When it starts**: The day after the bill receives Royal Assent (final approval from the Governor-General) - **Who's affected**: This mainly impacts how the government regulates, approves, and potentially funds new immunological products—patients would eventually see this through access to new treatment options

🔒 Voting closed — this bill has been decided by parliament